#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10904	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2022	529.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1388	1388	C	597	C	578	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10904	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2022	529.6	0	HET	.	.	.	C207T	.	207	207	C	411	411	C	654	C,T	498,127	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10904	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2022	529.6	0	HET	.	.	.	C451T	.	451	451	C	655	655	C	601	C,T	426,156	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20360	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3645	553.0	0	.	n	.	0	T695C	SNP	695	695	T	1032	1032	C	619	C	595	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20360	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3645	553.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2308	2308	C	626	C,T	603,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20360	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3645	553.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2382	2382	A	642	A	618	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20360	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3645	553.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2934	2934	C	607	C	595	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1200	folP	855	855	100.0	folP.l15.c4.ctg.1	1447	81.8	1	SNP	p	R229S	1	.	.	685	687	AGC	968	970	AGC	111;111;109	A;G;C	110;111;106	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3490	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3414	101.1	1	SNP	p	S91F	1	.	.	271	273	TTC	542	544	TTC	143;140;143	T;T;C	139;135;136	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3490	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3414	101.1	1	SNP	p	G95N	0	.	.	283	285	GGC	554	556	GGC	148;146;147	G;G;C	140;138;140	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3490	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3414	101.1	1	SNP	p	D95G	1	.	.	283	285	GGC	554	556	GGC	148;146;147	G;G;C	140;138;140	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1174	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1539	75.4	1	SNP	p	G45D	0	.	.	133	135	GGC	587	589	GGC	145;142;143	G;G;C	141;139;139	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	524	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1155	44.9	0	.	n	.	0	A197.	DEL	197	197	A	598	598	A	114	A	110	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4078	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2839	141.7	1	SNP	p	D86N	0	.	.	256	258	GAC	476	478	GAC	142;143;144	G;A;C	136;133;139	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4078	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2839	141.7	1	SNP	p	S87R	1	.	.	259	261	CGT	479	481	CGT	146;148;148	C,A;G;T	139,1;140;137	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4078	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2839	141.7	1	SNP	p	R87I	0	.	.	259	261	CGT	479	481	CGT	146;148;148	C,A;G;T	139,1;140;137	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4078	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2839	141.7	1	SNP	p	R87W	0	.	.	259	261	CGT	479	481	CGT	146;148;148	C,A;G;T	139,1;140;137	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4078	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2839	141.7	1	SNP	p	S88P	0	.	.	262	264	TCC	482	484	TCC	146;145;148	T;C;C	138;137;138	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2634	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2768	94.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1624	1626	GGC	122;121;123	G;G;C	118;117;115	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2768	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	114.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1234	1236	GCC	103;104;105	G;C;C,A	103;104;104,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2768	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	114.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1237	1239	ATG	105;105;105	A;T;G,C	105;105;104,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2768	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	114.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1249	1251	ACC	108;108;110	A,G,C;C,T;C,G	102,1,1;105,1;106,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2768	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	114.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1249	1251	ACC	108;108;110	A,G,C;C,T;C,G	102,1,1;105,1;106,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2768	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	114.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1750	1752	ACC	137;138;139	A;C;C,T	130;132;131,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2768	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	114.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1804	1806	GCG	129;130;130	G;C;G	126;128;126	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2768	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	114.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1804	1806	GCG	129;130;130	G;C;G	126;128;126	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2768	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	114.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1927	1929	GGT	114;111;111	G;G;T	107;105;102	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2768	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	114.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1936	1938	AGC	94;93;92	A;G;C	88;89;88	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2768	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2383	114.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1954	1956	CCG	82;82;84	C,G,T;C;G	68,2,1;68;74	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4348	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3075	139.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1627	1629	CCG	139;139;139	C;C;G	124;130;127	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1840	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1648	110.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	520	520	C	117	C	107	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2416	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1728	138.3	0	.	p	.	0	E209K	NONSYN	625	627	GAA	942	944	AAA	196;199;201	A,G;A;A	190,1;194;196	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2416	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1728	138.3	0	.	p	.	0	A212E	NONSYN	634	636	GCA	951	953	GAA	189;187;189	G,C;A;A	178,3;180;185	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2416	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1728	138.3	1	SNP	p	G120K	1	.	.	358	360	AAG	675	677	AAG	187;188;189	A;A;G	181;183;179	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2416	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1728	138.3	1	SNP	p	A121N	1	.	.	361	363	AAC	678	680	AAC	189;189;191	A,G;A;C	179,3;181;186	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2416	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1728	138.3	1	SNP	p	N121D	0	.	.	361	363	AAC	678	680	AAC	189;189;191	A,G;A;C	179,3;181;186	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8102	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4742	169.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	990	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1172	83.9	1	SNP	p	V57M	1	.	.	169	171	ATG	587	589	ATG	192;192;191	A;T;G,A	189;185;185,2	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
